Inactivated enzyme variants and associated process and reagent system

• US 7,517,664 B2
• Filed: 11/14/2006
• Issued: 04/14/2009
• Est. Priority Date: 10/28/2004
• Status: Expired due to Fees

• Current Assignee: Roche Diabetes Care Inc. (Roche Holding AG)
• Original Assignee: Roche Diagnostics Operations Incorporated (Roche Holding AG)
• Inventors: Knappe, Wolfgang-Reinhold, Shao, Zhixin, Hoenes, Joachim, Horn, Carina, Schmuck, Rainer
• Primary Examiner(s): Nashed; Nashaat T
• Assistant Examiner(s): MEAH, MOHAMMAD Y
• Application Number:
  US11/559,607
• Publication Number:
  US 20070087398A1
• Time in Patent Office: 882 Days
• Field of Search: None
• US Class Current: 435/14
• CPC Class Codes: C12N 9/0004 Oxidoreductases (1.)
• CPC Class Codes: C12N 9/0006 acting on CH-OH groups as donors (1.1)

Abstract

The present invention relates to oxidoreductase apoenzyme variants which are enzymatically inactive but have coenzyme-binding properties. Further, the present invention relates to DNA sequences encoding these oxidoreductase apoenzyme variants, expression vectors containing such DNA sequences and the use of these oxidoreductase apoenzyme variants in diagnostic applications.

Claims

1. A method for the determination of an analyte in a sample, comprising:

(a) providing a reagent comprising a glucose dehydrogenase variant of SEQ ID NO;

6, wherein said variant differs from SEQ ID NO;

6 by an amino acid substitution at position 145 or 158, said variant having less than 3% residual enzymatic activity relative to the wild type enzyme of B. subtilis and retaining more than 20% of the coenzyme binding activity of the wild type enzyme of B. subtilis;

(b) contacting a sample suspected to contain an analyte with the reagent in the presence of a coenzyme, under conditions wherein the amount of the coenzyme bound to the glucose dehydrogenase variant to form a coenzyme glucose dehydrogenase variant complex is indicative of the amount of analyte to be determined; and

(c) detecting the coenzyme glucose dehydrogenase variant complex.

2. The method of claim 1, wherein the glucose dehydrogenase variant has a threonine substitution at position 145 or a phenylalanine substitution at position 158 of the amino acid sequence of SEQ ID NO:

6.

3. The method of claim 2, wherein the glucose dehydrogenase variant has the amino acid sequence as shown in SEQ ID NO:

8 or SEQ ID NO;

10.

4. The method of claim 1, wherein the glucose dehydrogenase variant further comprises an amino acid segment capable of forming a metal chelate fused to said variant.

5. The method of claim 4, wherein the glucose dehydrogenase variant has the amino acid sequence as shown in SEQ ID NO:

14.

6. The method of claim 1, wherein the coenzyme is NAD(P)H.

7. The method of claim 1, wherein the coenzyme is formed by a reaction of an analyte with a precursor of the coenzyme, wherein the precursor is not capable of binding to the glucose dehydrogenase variant.

8. The method of claim 1, wherein the analyte is glucose.

9. The method of claim 1, wherein the sample is derived from a body fluid selected from serum, plasma, intestinal fluid or urine.

10. The method of claim 1, wherein the step of detecting the coenzyme glucose dehydrogenase variant complex is performed by measuring the fluorescence intensity.

11. The method of claim 1, wherein the reagent further comprising components for performing a liquid assay.

12. The method of claim 1, wherein the reagent further comprising components for performing a dry assay.